Sleep disruption, fatigue predict long-term risks of relapse, mortality after HCT
Among patients who have undergone allogeneic haematopoietic stem cell transplantation (HCT), biobehavioural symptoms, such as sleep disruption and fatigue interference, may signal a heightened risk of relapse and mortality over 6 years following HCT, according to a study.
Sleep disruption, fatigue predict long-term risks of relapse, mortality after HCT
29 Mar 2021
